References
1. Ostaszewski M, Mazein A, Gillespie
ME, Kuperstein I, Niarakis A, Hermjakob H, Pico AR, Willighagen EL,
Evelo CT, Hasenauer J, Schreiber F, Drager A, Demir E, Wolkenhauer O,
Furlong LI, Barillot E, Dopazo J, Orta-Resendiz A, Messina F, Valencia
A, Funahashi A, Kitano H, Auffray C, Balling R, Schneider R. COVID-19
Disease Map, building a computational repository of SARS-CoV-2
virus-host interaction mechanisms. Scientific data 2020; 7: 136.
2. Kawana A. SARS, MERS and
coronavirus infections. Nihon rinsho Japanese journal of clinical
medicine 2016; 74: 1967-72.
3. Petrosillo N, Viceconte G, Ergonul
O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely
related? Clinical microbiology and infection : the official publication
of the European Society of Clinical Microbiology and Infectious Diseases
2020.
4. Lo MK, Feldmann F, Gary JM, Jordan
R, Bannister R, Cronin J, Patel NR, Klena JD, Nichol ST, Cihlar T, Zaki
SR, Feldmann H, Spiropoulou CF, de Wit E. Remdesivir (GS-5734) protects
African green monkeys from Nipah virus challenge. Science translational
medicine 2019; 11.
5. Brown AJ, Won JJ, Graham RL, Dinnon
KH, 3rd, Sims AC, Feng JY, Cihlar T, Denison MR, Baric RS, Sheahan TP.
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic
deltacoronaviruses with a highly divergent RNA dependent RNA polymerase.
Antiviral research 2019; 169: 104541.
6. Yin W, Mao C, Luan X, Shen DD, Shen
Q, Su H, Wang X, Zhou F, Zhao W, Gao M, Chang S, Xie YC, Tian G, Jiang
HW, Tao SC, Shen J, Jiang Y, Jiang H, Xu Y, Zhang S, Zhang Y, Xu HE.
Structural basis for inhibition of the RNA-dependent RNA polymerase from
SARS-CoV-2 by remdesivir. Science 2020.
7. Zaki AM, van Boheemen S, Bestebroer
TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a
man with pneumonia in Saudi Arabia. The New England journal of medicine
2012; 367: 1814-20.
8. Minskaia E, Hertzig T, Gorbalenya
AE, Campanacci V, Cambillau C, Canard B, Ziebuhr J. Discovery of an RNA
virus 3’->5’ exoribonuclease that is critically involved in
coronavirus RNA synthesis. Proc Natl Acad Sci U S A 2006; 103: 5108-13.
9. Mulangu S, Dodd LE, Davey RT, Jr.,
Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D,
Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz
J, Lane HC, Muyembe-Tamfum JJ, Group PW, Sivahera B, Camara M, Kojan R,
Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka
S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum
M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley
L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y,
Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallee D, Nordwall
J, Team PCS. A Randomized, Controlled Trial of Ebola Virus Disease
Therapeutics. The New England journal of medicine 2019; 381: 2293-303.
10. Holshue ML, DeBolt C, Lindquist
S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S,
Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X,
Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK,
Washington State -nCo VCIT. First Case of 2019 Novel Coronavirus in the
United States. The New England journal of medicine 2020.
11. Wang M, Cao R, Zhang L, Yang X,
Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine
effectively inhibit the recently emerged novel coronavirus (2019-nCoV)
in vitro. Cell research 2020; 30: 269-71.
12. Agostini ML, Andres EL, Sims AC,
Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray
AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR.
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is
Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
mBio 2018; 9.
13. Beigel JH, Nam HH, Adams PL,
Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus
therapeutics - A meeting report from the 6th isirv Antiviral Group
conference. Antiviral research 2019; 167: 45-67.
14. Sheahan TP, Sims AC, Leist SR,
Schafer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO,
Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R,
Denison MR, Baric RS. Comparative therapeutic efficacy of remdesivir and
combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Nature communications 2020; 11: 222.
15. Sheahan TP, Sims AC, Graham RL,
Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY,
Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL,
Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison
MR, Baric RS. Broad-spectrum antiviral GS-5734 inhibits both epidemic
and zoonotic coronaviruses. Science translational medicine 2017; 9.
16. Grein J, Ohmagari N, Shin D, Diaz
G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX,
Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J,
Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham
J, D’Arminio Monforte A, Ismail S, Kato H, Lapadula G, L’Her E, Maeno T,
Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E,
Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A,
Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK,
Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs
R, Flanigan T. Compassionate Use of Remdesivir for Patients with Severe
Covid-19. The New England journal of medicine 2020.
17. Yeming W, Dingyu Z, Guanhua D,
Ronghui D, Jianping Z, Yang J, et al. Remdesivir in adults with severe
COVID-19: a randomised, double-blind, placebo-controlled, multicentre
trial. Lancet 2020; 10236, 1567-1578.
18. Reina J. [Remdesivir, the
antiviral hope against SARS-CoV-2]. Revista espanola de quimioterapia
: publicacion oficial de la Sociedad Espanola de Quimioterapia 2020.
19. Mullard A. Hints of hope with
remdesivir. Nature reviews Drug discovery 2020.
20. Warren TK, Jordan R, Lo MK, Ray
AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC,
Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL,
Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T,
Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss
JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E,
Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D,
Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun
MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL,
Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S. Therapeutic
efficacy of the small molecule GS-5734 against Ebola virus in rhesus
monkeys. Nature 2016; 531: 381-5.